Research-based biotechnology · Asia
Research-led biotechnology for active ingredients and better health access.
Ereky develops proprietary active ingredients, extracts, APIs and licensable biotechnology for pharmaceutical, functional-food, wellness and research partners—supported by research-use peptide synthesis.
Peptide synthesis is available as a secondary capability for qualified research organizations.What we do
From active-ingredient discovery to licensable science.
Core capabilities
Science with a commercial path.
Three focused platforms give partners a clear place to begin—from biotechnology R&D and proprietary active ingredients to supporting peptide-synthesis projects.
Biotechnology R&D
Research and development of new extracts, active food and beverage ingredients, cosmetic actives, APIs, formulations and licensable technologies.
See R&D capabilities →Active ingredient platforms
Commercial proprietary ingredients—including 3-Carene from Royal Thai jasmine and Halal Kaolin from Yala—supported by research, intellectual property and technical collaboration.
Explore active ingredients →Custom peptide synthesis
In-house, research-scale synthesis for qualified pharmaceutical companies, laboratories and educational institutions. Typical purity is 98–99%; scope is contract-defined.
Explore peptide capability →Proprietary ingredient platforms
Regional resources. Research-led value.
Our extraction work began in Southeast Asia with a commitment to create greater value from regional agricultural and natural resources.
3-Carene from Royal Thai jasmine
A commercially available active derived through Ereky’s water-based pressurized Halal extraction research, developed for pharmaceutical, food, supplement, oral-care and cosmetic applications.
Benefits and suitability are subject to product-specific technical and regulatory review.Halal Kaolin from Yala
A micronized mineral-clay platform developed from Yala sacred bleached white clay for cosmetic applications and research connected to Halal cleansing requirements.
Available for qualified ingredient and technology discussions.Our evolution
Rooted in Asia. Built for global collaboration.
GreenTech Biolab began after the Hat Yai flood, using agro-innovation research to help rebuild value around local crops.
The company became Ereky Co., Ltd., carrying its research and intellectual-property foundation forward.
Halal mineral-clay research expanded while the company grew its Bangkok presence and central production capability.
Ereky expanded research-use peptide synthesis and reshaped its strategy as a research-led biotechnology company.
Evidence through collaboration
An ecosystem around the science.
Research, public innovation support, technical collaboration and commercial relationships have helped Ereky develop from a regional research initiative into an international biotechnology platform.
Funding, research and institutional ecosystem
Selected customers and commercial relationships
Names and marks remain the property of their respective owners. Inclusion describes historical collaboration, grant support, participation, recognition, customer or commercial relationships; it does not imply endorsement.
Healthcare access should not depend on where you live.
Our vision
We believe affordable healthcare is a fundamental right. We envision a world where everyone can access care, anywhere, from the tip of their finger.
Our 2037 ambition: serve 10,000,000 customers.
Start a scientific conversation
What can we help you move forward?
Discuss a biotechnology R&D project, active-ingredient opportunity, quotation, licensing path, peptide-synthesis need or distribution partnership.